Matthieu De Kalbermatten profile page

Matthieu de Kalbermatten is the chief executive officer of CellProthera, a biotechnology company developing regenerative cell therapies for cardiovascular diseases. He has more than 20 years of experience in executive management, corporate strategy, and business development for medtech and large multinational companies. As the former executive vice president of ACROSTAK, de Kalbermatten specialized in the development of medical devices for interventional applications. He successfully led business development, sales, and marketing. de Kalbermatten holds a diploma in engineering from the Swiss Federal Institute of Technology, an MSc in engineering from the Tokyo Institute of Technology, and an executive MBA from the London Business School.